Muscle disorders cover a wide range of conditions that affect how muscles work, often causing weakness, cramps, low muscle tone (hypotonia), or trouble with movement. These issues can come from problems with the muscles themselves, nerves that contro...
Search Bar & Filters
Found 50 Actively Recruiting clinical trials
Actively Recruiting
This trial evaluates the safety and effectiveness of intravenous AOC 1044, also known as delpacibart zotadirsen, in treating boys aged 7 to 16 years with Duchenne Muscular Dystrophy DMD who have gene mutations that can be targeted by exon 44 skipping. The study is a phase 3, randomized, double-blind, placebo-controlled trial with a parallel design. It aims to assess how this treatment impacts physical abilities related to muscle function. Participants will be randomly assigned to receive either AOC 1044 or a placebo through intravenous infusion every 6 weeks for 54 weeks, totaling 9 doses during the double-blind treatment period. After this, all participants have the option to join a 54-week open-label extension, where everyone receives AOC 1044 infusions every 6 weeks for another 9 doses. The study concludes with assessments at week 108 and a safety follow-up at week 114. An independent committee will regularly review safety and efficacy data. During the study, participants will undergo various assessments including tests of muscle strength and function such as time to rise velocity, stair climb, and walkingrunning speed. Quality of life and global impression scores from both patients and caregivers will also be measured. Safety will be closely monitored throughout, with a total participation time of over two years, including the screening, treatment, extension, and follow-up periods.
Actively Recruiting
Researchers are evaluating whether silkworm pupa powder can improve the nutritional status, sarcopenia, frailty, quality of life, and cognitive function in patients with Alzheimers disease. This prospective, double-blind, randomized controlled clinical study aims to compare the effects of silkworm pupa powder against a placebo in people aged 50 to 90 years who meet specific Alzheimers disease diagnostic criteria. Participants will take either silkworm pupa powder or a placebo twice daily with warm water before meals for three months. Each dose consists of two packets 12 grams each taken two times a day. The study will include checkups and tests every four weeks during the treatment period to monitor effects and safety. During the study, participants will visit the clinic every four weeks for assessments including blood tests measuring hemoglobin, albumin, serum prealbumin, vitamin D, alkaline phosphatase, parathyroid hormone, and calcitonin. Imaging tests such as abdominal CT scans and head MRI will also be performed. Researchers will evaluate sarcopenia using diagnostic criteria and cognitive function with tools like the Mini-Mental State Examination and Clinical Dementia Rating. Participants will keep a daily diary of their consumption, and safety and health will be closely monitored throughout the trial lasting at least 12 weeks.
Actively Recruiting
Residual limping due to gluteus medius insufficiency after total hip replacement is a serious complication without effective treatment. This study aims to compare surgical reconstruction of the gluteus medius using an Achilles tendon allograft with non-surgical physiotherapy treatment. The hypothesis is that surgery followed by physiotherapy will improve hip function and reduce limping more than physiotherapy alone. Participants are randomly assigned to one of two groups. One group undergoes surgical reconstruction where an Achilles tendon allograft with a calcaneus block is fixed to the greater trochanter and tensioned through the gluteus medius muscle, followed by partial weight bearing for 2 months and 10 months of physiotherapy. The other group receives only physiotherapy for 12 months without surgery. Throughout the study, participants will be assessed at 12 months using the Oxford Hip Score to measure hip function. Additional evaluations include Trendelenburgs sign, hip abduction strength, activity levels, quality of life indexes, and monitoring of any adverse events. The total study duration for each participant is 12 months, with close observation of treatment outcomes and safety.
Actively Recruiting
This research aims to evaluate a long-term outpatient rehabilitation program using the Atalante X exoskeleton for adults with lower limb weakness or deficiencies caused by various conditions such as stroke, spinal cord injury, or neurodegenerative diseases. It addresses challenges in current rehabilitation care, like long wait times and limited accessibility, by exploring the potential benefits of robotic-assisted therapy over an extended period. Participants will engage in at least one exoskeleton rehabilitation session weekly during a 12-month intervention phase. These sessions involve ambulatory exercises with the Atalante X device, with intensity gradually increasing over time. After the initial year, participants may choose to continue in a voluntary extension phase for an additional year, following the same rehabilitation protocol. Throughout the study, participants will undergo assessments at the start, after 4 and 12 months, and for those in the extension phase, also at 16 and 24 months. These evaluations include tests of sitting function, walking ability, balance, muscle strength, cognitive function, and quality of life, along with monitoring of adverse events. The program also tracks detailed session data such as number of steps, session duration, and device assistance levels to understand adherence and impacts on motor and cognitive functions over time.
Actively Recruiting
This research investigates the safety and effectiveness of two forms of mexiletineprolonged-release PR and immediate-release IRin patients with non-dystrophic myotonias, including myotonia congenita, paramyotonia congenita, and sodium channel myotonia. This multicenter, open-label, randomized, cross-over study aims to compare these forms to better understand their effects on this condition. The study plans to enroll 24 patients, split evenly between those who are new to mexiletine treatment and those with previous treatment experience. Participants will undergo a 4-week screening followed by two 12-week treatment periods. Initially, patients will be randomly assigned to receive either mexiletine PR once daily or mexiletine IR three times daily. After a washout period of at least 7 days, they will switch to the other treatment for another 12 weeks. Different doses of mexiletine PR 167 mg, 333 mg, or 500 mg and mexiletine IR 167 mg are used to assess safety and efficacy. Throughout the study, participants will be closely monitored through patient and physician reports of adverse events, electrocardiograms ECGs, laboratory tests, physical exams, and vital signs. Efficacy will be measured using patient-reported outcomes and functional tests such as handgrip relaxation time, timed walking tests, and quality of life assessments. The main safety comparisons include heart rhythm intervals and rates, with observations continuing from baseline through week 24.
Actively Recruiting
Researchers are conducting a randomized trial to study the effects of supervised walking, led by specially trained mobility technicians MTs, on hospitalized medical patients aged 65 and older. The study aims to compare health outcomes and costs between patients receiving this assisted ambulation and those receiving usual care. It also seeks to identify which patients benefit most and assess the financial impact of the intervention over the hospital stay and 30 days afterward. Patients enrolled in the trial will be randomly assigned to either receive usual care or to have mobility technicians help them walk up to three times daily, every day including weekends, during their hospital stay for up to 10 days. The MTs will visit patients multiple times a day to encourage and assist with walking based on individual mobility scores and physical therapy recommendations, if available. All participants will wear wrist accelerometers to track their movement throughout their hospital stay. Participants will be closely monitored with various assessments including the Short Physical Performance Battery SPPB to measure mobility at discharge or after 10 days, and additional follow-ups at 30 days post enrollment to assess physical function, frailty, hospital complications, readmissions, and daily living activities. Researchers will also evaluate total costs related to the hospital stay and 30 days afterward. The study lasts up to 30 days per participant with ongoing safety and outcome monitoring.
Actively Recruiting
Healthy Volunteer
A significant number of Americans live with disabilities such as spinal cord injury, stroke, multiple sclerosis, ALS, spina bifida, cerebral palsy, and amputation. These disabilities often reduce activity levels and increase the risk of other health issues like obesity and insulin resistance. Regular exercise is important for maintaining health and combating muscle loss, especially as people age. This research evaluates whether low load blood flow restriction training can provide benefits similar to traditional high-intensity resistance training for people with disabilities. The study compares two types of exercise routines low load resistance training with blood flow restriction at 80% arterial occlusion pressure, and low load resistance training without blood flow restriction. Participants in both groups perform exercises at 30-50% of their one-repetition maximum. The blood flow restriction technique restricts blood flow to the muscles during exercise, which may help increase muscle size and strength with lighter loads. The study aims to see if low load blood flow restriction training is more beneficial than traditional low load training. Participants will engage in these training programs over 6 weeks. Researchers will measure changes in muscle strength, arm circumference, and muscle thickness to compare the effects between groups. The study also looks at how disability status interacts with training effects. Participants will be assessed regularly through physical exercises and measurements. Safety and health will be monitored throughout the study. The total participation duration and follow-up details are as outlined in the study plan.
Actively Recruiting
Infantile spasms are sudden, brief epileptic seizures characterized by rapid, repeated body contractions in flexion or extension, sometimes with eye movements. This condition is serious because delayed diagnosis and treatment can lead to cognitive decline. Diagnosing infantile spasms typically requires video-EEG, but this method is costly and not always accessible. To improve early detection, researchers are developing an automated system that analyzes simple smartphone or webcam videos using computer vision and learning models to identify spasms. The study aims to train this automated system by using a database of videos linked with electrophysiological data from pediatric neurophysiology labs. These videos have confirmed spasms based on expert analysis and video-EEG. The goal is for the system to reach over 95% sensitivity and specificity, allowing it to be used by healthcare professionals and families for early seizure detection and monitoring. This approach could facilitate faster referral and treatment, especially where access to specialized diagnostic tools is limited. Participants in this observational study include children up to 3 years old who have undergone video-EEG and have recorded spasms or other epilepsy types. Researchers will analyze existing video and EEG data to teach the system to distinguish spasms from other seizures. The primary outcome is achieving automated detection accuracy above 95% for spasms within two years. The study uses retrospective data from multiple hospitals and plans to publish results in a peer-reviewed journal.
Actively Recruiting
Researchers are conducting a 10-year observational study called the Congenital Muscle Disease Patient and Proxy Reported Outcome Study CMDPROS. This study aims to collect and analyze care data and adverse events for various congenital muscle diseases using the Congenital Muscle Disease International Registry CMDIR. The study focuses on individuals with diagnoses such as congenital muscular dystrophy, congenital myopathy, congenital myasthenic syndrome, and related conditions, including those without genetic confirmation. Understanding these conditions better will help improve care standards and support future clinical trials. Participants register in the CMDIR by providing demographic information and completing an intake survey. They are also asked to share medical records related to their diagnosis and treatment, such as genetic testing results, muscle biopsy reports, pulmonary function tests, sleep studies, clinic notes, and hospital discharge summaries. The study collects data on multiple disease subtypes and tracks various health events and care parameters over time, aiming to build a comprehensive database. Throughout the study, participants provide ongoing information about their health status and adverse events, which researchers verify using medical records. Key outcomes include survival rates, hospitalization frequency, respiratory complications, and other health complaints. The study will also analyze measures like ejection fraction, lung function, sleep study results, growth, fractures, and bone density. Data collected will contribute to evidence-based care guidelines and help identify meaningful outcomes for future clinical trials. Participation requires no travel as data collection is done remotely through the registry.
Actively Recruiting
This research aims to compare the effects of core stability exercises, scapular stabilization exercises, and a traditional physical therapy program on improving hand grip strength and reducing neck pain in adults with chronic myofascial neck pain CMNP. CMNP is a persistent and common musculoskeletal neck condition characterized by trigger points in the upper trapezius muscle, often leading to decreased muscle strength and hand function. The study addresses the mechanical connections between the core, scapula, and upper extremities, investigating how targeted exercises may influence pain, strength, and functional ability. Participants are divided into three groups one group performs core stability exercises combined with traditional physical therapy, another receives scapular stabilization exercises plus traditional therapy, and the third group undergoes only the traditional physical therapy program. Each program involves three sessions per week over six weeks, with exercise sessions lasting around 40 to 45 minutes including warm-up, main exercises, and cool-down stretches. Treatments focus on improving muscle function in the core and scapular regions to potentially enhance hand grip, pinch strength, and reduce neck pain. During the study, participants will be assessed at the start and after six weeks of treatment for hand grip strength, pinch grip strength, neck pain intensity, pain pressure threshold, and overall upper extremity function using specific scales and devices. Researchers will monitor these outcomes to evaluate the benefits of each exercise approach. The total study duration for each participant is six weeks, with regular evaluations to measure improvements and treatment effects.
1-10 of 50
1